Phase I study of nanoparticle albumin-bound paclitaxel, carboplatin and trastuzumab in women with human epidermal growth factor receptor 2-overexpressing breast cancer

Although the concurrent use of anthracycline-containing chemotherapy and taxane with trastuzumab are considered the treatment of choice for the primary systemic therapy of human epidermal growth factor receptor 2 (HER2)-overexpressing early breast cancer, non-anthracycline regimens, such as concurre...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Mol Clin Oncol
Main Authors: Tezuka, Kenji, Takashima, Tsutomu, Kashiwagi, Shinichiro, Kawajiri, Hidemi, Tokunaga, Shinya, Tei, Seika, Nishimura, Shigehiko, Yamagata, Shigehito, Noda, Satoru, Nishimori, Takeo, Mizuyama, Yoko, Sunami, Takeshi, Ikeda, Katsumi, Ogawa, Yoshinari, Onoda, Naoyoshi, Ishikawa, Tetsuro, Kudoh, Shinzoh, Takada, Minoru, Hirakawa, Kosei
Formato: Artigo
Idioma:Inglês
Publicado em: D.A. Spandidos 2017
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5374931/
https://ncbi.nlm.nih.gov/pubmed/28413662
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2017.1176
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados